Simulations Plus News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

02.04.20	Simulations Plus Acquires Lixoft, Expanding Modeling Software Offerings and Broadening Presence in Europe (Businesswire)
26.03.20	Simulations Plus Offers Rapid Response COVID-19 Research Initiative (Businesswire)
18.03.20	Sandra Suarez-Sharp Joins Simulations Plus to Lead Regulatory Strategies Team (Businesswire)
04.02.20	DILIsym Services Partners with Large Pharmaceutical Company to Begin QSP Model Development for Heart Failure (Businesswire)
13.01.20	Simulations Plus to Present at the 22nd Annual Needham Growth Conference (Businesswire)
09.01.20	Simulations Plus Reports Record First Quarter FY2020 Financial Results (Businesswire)
03.01.20	Simulations Plus Sets Date for First Quarter Fiscal Year 2020 Earnings Release and Conference Call (Businesswire)
05.12.19	Simulations Plus Partners with Bayer AG to Develop New Cheminformatics Capabilities in ADMET Predictor (Businesswire)
21.11.19	Simulations Plus Partners with Large Pharmaceutical Company to Add New Capabilities to PKPlus (Businesswire)
14.11.19	Simulations Plus Partners with Large Pharmaceutical Company to Enhance the Mechanistic Oral Absorption (ACAT) Model in GastroPlus (Businesswire)
13.11.19	Simulations Plus Reports FY2019 and Fourth Quarter FY2019 Financial Results (Businesswire)
06.11.19	Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2019 Earnings Release and Conference Call (Businesswire)
29.10.19	Simulations Plus to Support Development of Radiation Countermeasure via New QSP Platform (RADAsym) and Pharmacometrics Modeling (Businesswire)
17.10.19	Simulations Plus Partners with Large Pharmaceutical Company to Develop the Virtual Bioequivalence Trial Simulator™ Module (Businesswire)
14.10.19	Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share (Businesswire)
02.10.19	Simulations Plus Announces Leadership Changes at Cognigen (Businesswire)
04.09.19	Simulations Plus Partners with Clinical-Stage Biotech Company to Develop Novel Dosing Models (Businesswire)
16.07.19	Simulations Plus Enters into New Research Collaboration Agreement with the FDA (Businesswire)
10.07.19	Simulations Plus Reports Third Quarter FY2019 Financial Results (Businesswire)
09.07.19	Simulations Plus Upgrades PKPlus™ (Businesswire)
08.07.19	Ausblick: Simulations Plus vermeldet Zahlen zum jüngsten Quartal (finanzen.net)
02.07.19	Simulations Plus Sets Date for 3rd Quarter 2019 Earnings Release and Conference Call (Businesswire)
27.06.19	DILIsym Releases NAFLDsym® Version 2A (Businesswire)
18.06.19	Simulations Plus Upgrades Flagship GastroPlus (Businesswire)
11.06.19	Cognigen Launches KIWI Version 4.0 (Businesswire)
21.05.19	PMDA Adds Licenses of GastroPlus® (Businesswire)
16.05.19	U.S. FDA Renews DILIsym Software Licenses (Businesswire)
14.05.19	Simulations Plus to Present at B. Riley FBR Investor Conference on May 22, 2019 (Businesswire)
01.05.19	Lisa LaVange, PhD, Appointed to Board of Directors of Simulations Plus (Businesswire)
30.04.19	FDA Purchases Bundle of ADMET Predictor® Licenses (Businesswire)
11.04.19	Simulations Plus Releases ADMET Predictor® Version 9.5 (Businesswire)
09.04.19	Simulations Plus Reports Record Second Quarter FY2019 Revenue (Businesswire)
07.04.19	Ausblick: Simulations Plus stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net)
02.04.19	Simulations Plus Sets Date for 2nd Quarter 2019 Earnings Release and Conference Call (Businesswire)
17.01.19	DILIsym Awarded $1.5 Million Phase II NIH Grant (Businesswire)
15.01.19	Simulations Plus Releases DDDPlus™ Version 6 (Businesswire)
14.01.19	DILIsym Services Inc. Initiates Development of IPFsym™ (Businesswire)
10.01.19	Simulations Plus to Present at the 21st Annual Needham Growth Conference (Businesswire)
09.01.19	Simulations Plus Reports First Quarter FY2019 Financial Results (Businesswire)
07.01.19	DILIsym Services Inc. Releases DILIsym® Version 8A (Businesswire)
07.01.19	Ausblick: Simulations Plus stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net)
02.01.19	Simulations Plus to Report First Quarter Fiscal Year 2019 Financial Results (Businesswire)
20.11.18	Simulations Plus to Present at LD Micro 11th Annual Main Event Investor Conference on December 4, 2018 (Businesswire)
14.11.18	Simulations Plus Reports FY2018 and Fourth Quarter FY2018 Financial Results (Businesswire)
12.11.18	Ausblick: Simulations Plus stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net)
07.11.18	Simulations Plus to Report 4th Quarter and Fiscal Year 2018 Financial Results (Businesswire)
06.11.18	DILIsym Services, an SLP Company, Launches Consortium for Drug-Related Kidney Injury (Businesswire)
22.10.18	Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share (Businesswire)
12.09.18	Simulations Plus Receives New Grant Award from the FDA (Businesswire)
05.09.18	Simulations Plus Extends Funded Research Collaboration with the FDA (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’282.00	1.18 %	K V
Kuehne+Nagel Int	203.70	0.54 %	K V
Alcon	76.68	0.47 %	K V
Holcim	89.10	0.27 %	K V
Logitech Intl	74.96	0.13 %	K V
Swisscom	502.50	-0.89 %	K V
Sika	223.80	-1.06 %	K V
Nestle	73.86	-1.81 %	K V
Swiss Re	129.50	-1.86 %	K V
Givaudan	3’983.00	-1.92 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Simulations Plus IncShs

Aktien Top/Flop

Meistgelesene Nachrichten